<i>HER2/neu</i> Oncogene Silencing in a Breast Cancer Cell Model Using Cationic Lipid-Based Delivery Systems
The overexpression of the human epidermal growth factor 2 (<i>HER2/neu</i>) oncogene is predictive of adverse breast cancer prognosis. Silencing the <i>HER2/neu</i> overexpression using siRNA may be an effective treatment strategy. Major requirements for siRNA-based therapy a...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Llibre |
| Publicat: |
MDPI AG,
2023-04-01T00:00:00Z.
|
| Matèries: | |
| Accés en línia: | Connect to this object online. |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Internet
Connect to this object online.3rd Floor Main Library
| Signatura: |
A1234.567 |
|---|---|
| Còpia 1 | Disponible |